BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsianos EV, Katsanos KH, Tsianos VE. Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol 2012; 18(2): 105-118 [PMID: 22253516 DOI: 10.3748/wjg.v18.i2.105]
URL: https://www.wjgnet.com/1007-9327/full/v18/i2/105.htm
Number Citing Articles
1
Tao Jiang, Beibei Qin, Jianqin He, Shuangyan Lin, Shiping Ding. Three isoforms of the Atg16L1 protein contribute different autophagic propertiesMolecular and Cellular Biochemistry 2013; 378(1-2): 257 doi: 10.1007/s11010-013-1616-8
2
Yu Wen Li, Ci Qiu Yang, Ying Lian Xiao, Jie Li, Chen Xi Xie, Sheng Hong Zhang, Qiao Yu, Hui Ling Wang, Wei Ming Lu, Min Hu Chen. The ‐A2518G polymorphism in the MCP‐1 gene and inflammatory bowel disease risk: A meta‐analysisJournal of Digestive Diseases 2015; 16(4): 177 doi: 10.1111/1751-2980.12232
3
Vahab Alamdari-Palangi, Farzaneh Vahedi, Zahra Shabaninejad, Sadat Dokeneheifard, Ahmad Movehedpour, Mortaza Taheri-Anganeh, Amir Savardashtaki. microRNA in inflammatory bowel disease at a glanceEuropean Journal of Gastroenterology & Hepatology 2021; 32(2): 140 doi: 10.1097/MEG.0000000000001815
4
Mario García-Domínguez. Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic PerspectivesBiomolecules 2024; 14(8): 926 doi: 10.3390/biom14080926
5
Iván Igaz, Mihály Szőnyi, Patrícia Varga, Lajos Topa. Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseasesOrvosi Hetilap 2014; 155(13): 487 doi: 10.1556/OH.2014.29864
6
Faizan Alawi. An Update on Granulomatous Diseases of the Oral TissuesDental Clinics of North America 2013; 57(4): 657 doi: 10.1016/j.cden.2013.07.004
7
Irene Fung, Jackie P.-D. Garrett, Anupama Shahane, Mildred Kwan. Do Bugs Control Our Fate? The Influence of the Microbiome on AutoimmunityCurrent Allergy and Asthma Reports 2012; 12(6): 511 doi: 10.1007/s11882-012-0291-2
8
Marianne R. Spalinger, Silvia Lang, Achim Weber, Pascal Frei, Michael Fried, Gerhard Rogler, Michael Scharl. Loss of Protein Tyrosine Phosphatase Nonreceptor Type 22 Regulates Interferon-γ–Induced Signaling in Human MonocytesGastroenterology 2013; 144(5): 978 doi: 10.1053/j.gastro.2013.01.048
9
Beatrice E Torere, Henry O Aiwuyo, Jennifer L Kennard. Leukocytoclastic Vasculitis and Myositis as Initial Manifestations of Crohn’s DiseaseCureus 2022;  doi: 10.7759/cureus.33127
10
Mohammad Salem, Jakob Benedict Seidelin, Gerhard Rogler, Ole Haagen Nielsen. Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyondCellular and Molecular Life Sciences 2013; 70(18): 3391 doi: 10.1007/s00018-012-1246-4
11
Anna Duda-Madej, Jakub Stecko, Natalia Szymańska, Agnieszka Miętkiewicz, Marta Szandruk-Bender. Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1393809
12
Dipanwita Kapoor, Kathy Teahon, Suzanne VF Wallace. Inflammatory bowel disease in pregnancyThe Obstetrician & Gynaecologist 2016; 18(3): 205 doi: 10.1111/tog.12271
13
Pedro Gonçalves, Fernando Magro, Fátima Martel. Metabolic Inflammation in Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2015; 21(2): 453 doi: 10.1097/MIB.0000000000000209
14
Jin Soo Moon. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel DiseasesPediatric Gastroenterology, Hepatology & Nutrition 2019; 22(1): 50 doi: 10.5223/pghn.2019.22.1.50
15
Ria Margiana, Hamzah H. Kzar, Fadhil Hussam, Noora M. Hameed, Zahraa Haleem Al-qaim, Moaed E. Al-Gazally, Mahmoud Kandee, Marwan Mahmood Saleh, Bobur Bakhrom ugli Toshbekov, Farkhod Tursunbaev, Sajad Karampoor, Rasoul Mirzaei. Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseasesPathology - Research and Practice 2023; 248: 154705 doi: 10.1016/j.prp.2023.154705
16
Raquel Franco Leal, Marciane Milanski, Cláudio Saddy Rodrigues Coy, Mariana Portovedo, Viviane Soares Rodrigues, Andressa Coope, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Lício Augusto Velloso. Autophagy and proinflammatory cytokine expression in the intestinal mucosa and mesenteric fat tissue of patients with Crohn's diseaseJournal of Coloproctology 2013; 33(01): 009 doi: 10.1016/j.jcol.2012.10.001
17
ManzoorA Malik. MDR1C3435T polymorphism and inflammatory bowel diseaseSaudi Journal of Gastroenterology 2015; 21(2): 121 doi: 10.4103/1319-3767.153843
18
Aysegul Sagir Kahraman. Editorial for “Novel Associations Between Genome‐Wide Single Nucleotide Polymorphisms and MR Enterograpy Features in Crohn's Disease Patients”Journal of Magnetic Resonance Imaging 2021; 53(1): 139 doi: 10.1002/jmri.27356
19
Jixiang Zhang, Jianhong Wu, Xiulan Peng, Jia Song, Jun Wang, Weiguo Dong, Georgina L. Hold. Associations between STAT3 rs744166 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-AnalysisPLoS ONE 2014; 9(10): e109625 doi: 10.1371/journal.pone.0109625
20
Sanjana Vijay Nemade, Kiran Jaywant Shinde. Granulomatous diseases in Otorhinolaryngology, Head and Neck2021; : 207 doi: 10.1007/978-981-16-4047-6_23
21
Xiaolei Wang, Li Qin, Jingli Cao, Jing Zhao. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn’s disease: a systematic review and meta-analysisCurrent Medical Research and Opinion 2016; 32(12): 2007 doi: 10.1080/03007995.2016.1226168
22
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2019; 2019(11) doi: 10.1002/14651858.CD012878.pub2
23
Sanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, Aleksandra Sokic-Milutinovic, Snezana Lukic, Tamara Alempijevic, Branka Zukic, Nikola Kotur, Gordana Nikcevic, Sonja Pavlovic, Dragan Popovic. Genetic and environmental factors significant for the presentation and development of inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2017; 29(8): 909 doi: 10.1097/MEG.0000000000000877
24
Matthew A. Croxen, Robyn J. Law, Roland Scholz, Kristie M. Keeney, Marta Wlodarska, B. Brett Finlay. Recent Advances in Understanding Enteric Pathogenic Escherichia coliClinical Microbiology Reviews 2013; 26(4): 822 doi: 10.1128/CMR.00022-13
25
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD012878
26
Yongchun Shen, Shujin Guo, Ting Yang, Liuqun Jia, Lei Chen, Jing An, Tao Wang, Fuqiang Wen. The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-AnalysisInternational Journal of Molecular Sciences 2013; 14(6): 11392 doi: 10.3390/ijms140611392
27
Naif Alenazi, Hesham Alsaeed, Adel Alsulami, Turki Alanzi. A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel DiseaseInternational Journal of General Medicine 2021; : 7099 doi: 10.2147/IJGM.S336678
28
Bruno Lorenzo SCOLARO, Emily dos SANTOS, Leslie Ecker FERREIRA, Paulo Henrique Condeixa de FRANÇA, Harry KLEINUBING, Paulo Gustavo KOTZE, Mauro de Souza Leite PINHO. T300A GENETIC POLYMORPHISM: a susceptibility factor for Crohn’s disease?Arquivos de Gastroenterologia 2014; 51(2): 97 doi: 10.1590/S0004-28032014000200005
29
Mingwei Zhang, Tian Qiu, Wenbing Yang, Zhipeng Zhang, Bokai Shi. Bi-omics prognostic model for invasive ductal carcinoma using deep learningProceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science 2023; : 682 doi: 10.1145/3644116.3644229
30
Raquel F. Leal, Francesca A. Ramos Silva. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging2017; : 313 doi: 10.1016/B978-0-12-812146-7.00014-7
31
Cinthia Cruz‐Romero, Abra Guo, William F. Bradley, Joao R.T. Vicentini, Vijay Yajnik, Michael S. Gee. Novel Associations Between Genome‐Wide Single Nucleotide Polymorphisms and MR Enterography Features in Crohn's Disease PatientsJournal of Magnetic Resonance Imaging 2021; 53(1): 132 doi: 10.1002/jmri.27250
32
Dana Mahr. History of Human Genetics2017; : 325 doi: 10.1007/978-3-319-51783-4_20
33
Diana Lacruz-Guzmán, Daniel Torres-Moreno, Francisco Pedrero, Patricia Romero-Cara, Iván García-Tercero, Javier Trujillo-Santos, Pablo Conesa-Zamora. Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitisEuropean Journal of Clinical Pharmacology 2013; 69(3): 431 doi: 10.1007/s00228-012-1389-0
34
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. ACG Clinical Guideline: Management of Crohn's Disease in AdultsAmerican Journal of Gastroenterology 2018; 113(4): 481 doi: 10.1038/ajg.2018.27
35
Eiichi Momotani, Hiroshi Ozaki, Masatoshi Hori, Shizuo Yamamoto, Takashi Kuribayashi, Shigetoshi Eda, Masahiro Ikegami. Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn’s disease-type necrotizing colitis in MiceSpringerPlus 2012; 1(1) doi: 10.1186/2193-1801-1-47
36
Jin Soo Moon. Clinical aspects and treatments for pediatric inflammatory bowel diseaseIntestinal Research 2019; 17(1): 17 doi: 10.5217/ir.2018.00139
37
Ivana Kern, Olaf Schoffer, Thomas Richter, Wieland Kiess, Gunter Flemming, Ulf Winkler, Jürgen Quietzsch, Olaf Wenzel, Marlen Zurek, Ulf Manuwald, Janice Hegewald, Shi Li, Jens Weidner, Jan de Laffolie, Klaus-Peter Zimmer, Joachim Kugler, Martin W. Laass, Ulrike Rothe, Mathilde Body-Malapel. Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000–2014 –a 15-year evaluation of trendsPLOS ONE 2022; 17(9): e0274117 doi: 10.1371/journal.pone.0274117
38
Anna Monica Bianco, Valentina Zanin, Lorenzo Monasta, Stefano Martelossi, Annalisa Marcuzzi, Sergio Crovella. Family history in early-onset inflammatory bowel diseaseJournal of Gastroenterology 2013; 48(1): 144 doi: 10.1007/s00535-012-0654-4
39
Plamen K. Krastev, Alexander B. Blazhev, Galya Ts. Stavreva. Effect of Aminosteroid U74389G in a Model of Inflammatory Bowel Disease in RatsJournal of Biomedical and Clinical Research 2021; 14(2): 131 doi: 10.2478/jbcr-2021-0018
40
Seana ML Nelson, Tran M Nguyen, John WD McDonald, John K MacDonald. Natalizumab for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2018; 2018(8) doi: 10.1002/14651858.CD006097.pub3
41
Ji-Xiang Zhang, Jia Song, Jun Wang, Wei-Guo Dong. JAK2 rs10758669 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-analysisInflammation 2014; 37(3): 793 doi: 10.1007/s10753-013-9798-5